➀ The US Chips and Science Act's main goal, to restore the US as a manufacturer of leading-edge logic ICs, is in jeopardy due to a disconnect between US bureaucracy and Intel. ➁ Intel, the only US company with a plan to produce these ICs, has not received any of the $19.5 billion in grants and loans promised under the Act. ➂ The delay in funding is due to officials waiting for Intel to show progress in building infrastructure, while Intel is unable to invest in new fabs due to the chip demand slump.
Related Articles
- My Favorite 10 Real-Money Blue-Chip Bargains To Buy In August3 months ago
- 2 Dividend Stocks I'm Wildly Bullish On6 months ago
- Jiang Shangyi: Intel is Now a 'Minor Player', Should Merge with Established Chip Technology Companies7 months ago
- Intel’s 18A on-track for production ramp next year, says foundry GM11 months ago
- Samsung Foundry strugglesabout 1 year ago
- Intel Reportedly Eyes Retired TSMC Veteran Wei-Jen Lo to Lead R&D5 days ago
- Intel Reaffirms 14A, Deepens Nvidia Alliance9 days ago
- Intel's pivotal 18A process is making steady progress, but still lags behind — yields only set to reach industry standard levels in 202710 days ago
- Intel posts return to growth and profitability in Q3 2025, but significant challenges remain — achieves $13.7 billion revenue with $4.1 billion operating profit10 days ago
- Trump administration to follow up Intel stake with investment in quantum computing, report claims — tens of millions of CHIPS Act dollars could be paid out to leading companies in exchange for equity11 days ago